Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG)

Clinical Microbiology and Infection

Volumn 15, Issue 4, 2009, Pages 341-346

  Osterburg, A ^a,d   Gardner, J ^a   Hyon, S H ^b   Neely, A ^a,c   Babcock, G ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF CINCINNATI   (United States)

^d NONE   (United States)

Author keywords

A. baumannii; Antibiotic resistance; Burns; EGCG; Polyphenols; Topical

Indexed keywords

EPIGALLOCATECHIN GALLATE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TEA;

ACINETOBACTER BAUMANNII; CAMELLIA;

EID: 65449120729     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02710.x     Document Type: Article

References (27)

1. Jones A, Morgan D, Walsh A et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006; 6: 317-318.
2. Hawley JS, Murray CK, Griffith ME et al. Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob Agents Chemother 2007; 51: 376-378.
3. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9: 148-165.
4. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43 (suppl 2): S49-S56.
5. Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 2946-2950.
6. Kuriyama S, Shimazu T, Ohmori K et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. JAMA 2006; 296: 1255-1265.
7. Yang CS, Lambert JD, Ju J, Lu G, Sang S. Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol 2007; 224: 265-273.
8. Friedman M, Henika PR, Levin CE, Mandrell RE, Kozukue N. Antimicrobial activities of tea catechins and theaflavins and tea extracts against Bacillus cereus. J Food Prot 2006; 69: 354-361.
9. Yoda Y, Hu ZQ, Zhao WH, Shimamura T. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother 2004; 10: 55-58.
10. Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int J Biochem Cell Biol 2006; 38: 600-609.
11. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun 2006; 347: 401-405.
12. Yanagawa Y, Yamamoto Y, Hara Y, Shimamura T. A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro. Curr Microbiol 2003; 47: 244-249.
13. Isbrucker RA, Bausch J, Edwards JA, Wolz E. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity. Food Chem Toxicol 2006; 44: 626-635.
14. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies. Food Chem Toxicol 2006; 44: 636-650.
15. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, 7th edn. CLSI document M7-A7. Wayne, PA: CLSI, 2006.
16. Isenberg HD, American Society for Microbiology. Clinical microbiology procedures handbook, 2nd edn. Washington, DC: ASM Press, 2004.
17. Ikigai H, Nakae T, Hara Y, Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1993; 1147: 132-136.
18. Hamilton-Miller JM, Shah S. Disorganization of cell division of methicillin-resistant Staphylococcus aureus by a component of tea (Camellia sinensis): A study by electron microscopy. FEMS Microbiol Lett 1999; 176: 463-469.
19. Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JM, Taylor PW. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int J Antimicrob Agents 2004; 23: 462-467.
20. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1737-1742.
21. Yam TS, Hamilton-Miller JM, Shah S. The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2′ synthesis, and beta-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 1998; 42: 211-216.
22. Zhao WH, Hu ZQ, Hara Y, Shimamura T. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 2266-2268.
23. Zhao WH, Asano N, Hu ZQ, Shimamura T. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase. J Pharm Pharmacol 2003; 55: 735-740.
24. Nielsen JB, Lampen JO. Membrane-bound penicillinases in Gram-positive bacteria. J Biol Chem 1982; 257: 4490-4495.
25. Bjornsson E, Olsson R. Serious adverse liver reactions associated with herbal weight-loss supplements. J Hepatol 2007; 47: 295-297. Author reply 297-298.
26. Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern. J Hepatol 2006; 45: 334-335. Author reply 335-336.
27. Bessey PQ. Wound care. In: Herndon DN, ed., Total burn care. Philadelphia, PA: Elsevier, 2007; 127-135.